US lawmakers seek to undercut Chinese AI and tech sales abroad

U.S. senators plan to unveil a bill on Tuesday that would create a State Department office to subsidize allied purchases of American AI technology, backed by a proposed $500 million fund. The measure is designed to counter Chinese AI exports and reduce dependence on China across AI chips, models, software, hardware, telecom equipment, cybersecurity, biotech, and cloud systems. The effort supports the Trump administration’s Pax Silica initiative and highlights escalating competition over critical AI supply chains.

Analysis

The market is likely underestimating how much of this is a procurement-and-subsidy story rather than a pure demand surprise. If Washington helps allied governments finance and streamline purchases, the incremental winners are the companies that already have exportable, compliance-friendly stacks and the sales channels to win sovereign deals; that tends to favor diversified platform names more than single-node hardware vendors. In practice, this should shift bargaining power toward U.S. vendors with higher software/content mix and away from commoditized chip assembly where margins are most exposed to pricing pressure.

For SMCI, the setup is more nuanced than a simple AI capex tailwind. Any policy that broadens access to U.S. AI infrastructure can keep headline demand elevated, but it also accelerates competition among suppliers and raises the odds that customers delay orders while waiting for subsidized procurement programs to clear. That creates a near-term air pocket risk: the equity can remain bid on the theme, but multiple compression is plausible over the next 1-3 months if investors decide the policy benefit is slower-moving than the current positioning implies.

APP is the cleaner second-order beneficiary because government-facing cyber, identity, and edge-adjacent software tends to gain from procurement simplification and cybersecurity emphasis. The contrarian view is that the trade is not as bullish for semis as the market may want to believe; the more durable edge may accrue to vendors that help agencies operationalize and secure the stack, not the chip makers supplying it. If this bill gains traction, expect allies to favor bundled, managed deployments over bespoke hardware buys, which is a subtle but important headwind for pure-play infrastructure names.

The main reversal risk is political: if the bill stalls, the market may quickly fade the geopolitical premium, especially in names that have already run on AI scarcity narratives. Over 6-12 months, however, the direction of travel is still supportive for U.S. exportable tech, because China’s low-cost offering remains a structural forcing function for allied procurement decisions. The key is timing: this is likely a better relative-value than outright-beta expression until funding and implementation details become concrete.

Key Decisions for Investors

• Long APP vs short SMCI for 1-3 months: APP has a cleaner policy-through-procurement tailwind, while SMCI is more exposed to multiple compression if the market decides the bill is slower to monetize. Target 10-15% relative outperformance if AI infrastructure sentiment stays firm.
• Buy SMCI downside protection: add 1-2 month put spreads into strength, financed against existing exposure, to protect against a 15-20% drawdown if the market rotates from hardware scarcity to policy execution risk.
• Initiate a small tactical long in cyber/software enablers over hardware-heavy AI names: use APP as the proxy, or a basket long APP / short a hardware basket, on the thesis that government procurement favors compliance, security, and deployment software.
• Wait for confirmation before adding to AI-semiconductor beta: if the bill advances and funding is appropriated, reassess after the next procurement headlines; until then, treat the move as sentiment-positive but earnings-light over the next quarter.
• If already long AI complex, rotate part of the book toward relative winners with software content and away from pure hardware suppliers; the risk/reward is better in names that can capture subsidy-adjacent spend without depending on immediate capex acceleration.